PlainRecalls
FDA Drug Low Class III Ongoing

Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-dose pump, Rx Only, Manufactured by DPT Laboratories, Ltd San Antonio, TX 78215, Manufactured for: Perrigo, Allegan, Minnapolis, MN 55427, NDC: 0574-2067-27

Reported: March 22, 2023 Initiated: February 21, 2023 #D-0464-2023

Product Description

Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-dose pump, Rx Only, Manufactured by DPT Laboratories, Ltd San Antonio, TX 78215, Manufactured for: Perrigo, Allegan, Minnapolis, MN 55427, NDC: 0574-2067-27

Reason for Recall

Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.

Details

Recalling Firm
Padagis US LLC
Units Affected
43,238 cartons
Distribution
Nationwide in the USA
Location
Minneapolis, MN

Frequently Asked Questions

What product was recalled?
Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-dose pump, Rx Only, Manufactured by DPT Laboratories, Ltd San Antonio, TX 78215, Manufactured for: Perrigo, Allegan, Minnapolis, MN 55427, NDC: 0574-2067-27. Recalled by Padagis US LLC. Units affected: 43,238 cartons.
Why was this product recalled?
Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 22, 2023. Severity: Low. Recall number: D-0464-2023.